Hat mitgewirkt an:
-
Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail
-
Das Cytochrom-P450-Enzym CYP1A2 des Menschen : Grundlagen der Aktivitätsbestimmung und Arzneimittelinteraktionen durch Inhibitoren
-
Improved correction formulas to estimate iohexol clearance from simple models
-
Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients